O-7 Adjuvant nivolumab vs placebo in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: First report of comprehensive biomarker analyses from CheckMate 577
Authors:
- 1 July 2023
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 34, S183